Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Egbert Oosterwijk

Showing results (151-160 of 190) with videos related to

Pageof 19
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 30, 2006
The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCONRuth A Jonathan, Karien I E M Wijffels, Wenny Peeters, et al.
Neoplasia (New York, N.Y.)|April 15, 2014
Neoadjuvant sorafenib treatment of clear cell renal cell carcinoma and release of circulating tumor fragmentsGursah Kats-Ugurlu, Egbert Oosterwijk, Stijn Muselaers, et al.
World Journal of Urology|November 6, 2007
Polymorphisms in genes related to activation or detoxification of carcinogens might interact with smoking to increase renal cancer risk: results from The Netherlands Cohort Study on diet and cancerKim M Smits, Leo J Schouten, Boukje A C van Dijk, et al.
World Journal of Urology|December 11, 2014
Urinary cytokines in patients treated with intravesical mitomycin-C with and without hyperthermiaTom J H Arends, Johannes Falke, Rianne J M Lammers, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 20, 2010
111In-bevacizumab imaging of renal cell cancer and evaluation of neoadjuvant treatment with the vascular endothelial growth factor receptor inhibitor sorafenibIngrid M E Desar, Alexander B Stillebroer, Egbert Oosterwijk, et al.
European Urology|September 18, 2012
Phase 1 radioimmunotherapy study with lutetium 177-labeled anti-carbonic anhydrase IX monoclonal antibody girentuximab in patients with advanced renal cell carcinomaAlexander B Stillebroer, Otto C Boerman, Ingrid M E Desar, et al.
International Journal of Cancer|April 23, 2009
Targeted therapy of renal cell carcinoma: synergistic activity of cG250-TNF and IFNgStefan Bauer, Jeannette C Oosterwijk-Wakka, Nicole Adrian, et al.
Tissue Engineering. Part C, Methods|October 9, 2013
Seamless vascularized large-diameter tubular collagen scaffolds reinforced with polymer knittings for esophageal regenerative medicineHenk R Hoogenkamp, Martin J W Koens, Paul J Geutjes, et al.
European Journal of Cancer (Oxford, England : 1990)|February 28, 2012
Modest improvement in 20 years of kidney cancer care in the NetherlandsSaskia A M van de Schans, Katja K H Aben, Peter F A Mulders, et al.
RSC Advances|May 11, 2022
A salt-based method to adapt stiffness and biodegradability of porous collagen scaffoldsLuuk R Versteegden, Marije Sloff, Henk R Hoogenkamp, et al.
Pageof 19

Showing results (151-160 of 190) with videos related to

Sort By:
Pageof 19
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 30, 2006
The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCONRuth A Jonathan, Karien I E M Wijffels, Wenny Peeters, et al.
Neoplasia (New York, N.Y.)|April 15, 2014
Neoadjuvant sorafenib treatment of clear cell renal cell carcinoma and release of circulating tumor fragmentsGursah Kats-Ugurlu, Egbert Oosterwijk, Stijn Muselaers, et al.
World Journal of Urology|November 6, 2007
Polymorphisms in genes related to activation or detoxification of carcinogens might interact with smoking to increase renal cancer risk: results from The Netherlands Cohort Study on diet and cancerKim M Smits, Leo J Schouten, Boukje A C van Dijk, et al.
World Journal of Urology|December 11, 2014
Urinary cytokines in patients treated with intravesical mitomycin-C with and without hyperthermiaTom J H Arends, Johannes Falke, Rianne J M Lammers, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 20, 2010
111In-bevacizumab imaging of renal cell cancer and evaluation of neoadjuvant treatment with the vascular endothelial growth factor receptor inhibitor sorafenibIngrid M E Desar, Alexander B Stillebroer, Egbert Oosterwijk, et al.
European Urology|September 18, 2012
Phase 1 radioimmunotherapy study with lutetium 177-labeled anti-carbonic anhydrase IX monoclonal antibody girentuximab in patients with advanced renal cell carcinomaAlexander B Stillebroer, Otto C Boerman, Ingrid M E Desar, et al.
International Journal of Cancer|April 23, 2009
Targeted therapy of renal cell carcinoma: synergistic activity of cG250-TNF and IFNgStefan Bauer, Jeannette C Oosterwijk-Wakka, Nicole Adrian, et al.
Tissue Engineering. Part C, Methods|October 9, 2013
Seamless vascularized large-diameter tubular collagen scaffolds reinforced with polymer knittings for esophageal regenerative medicineHenk R Hoogenkamp, Martin J W Koens, Paul J Geutjes, et al.
European Journal of Cancer (Oxford, England : 1990)|February 28, 2012
Modest improvement in 20 years of kidney cancer care in the NetherlandsSaskia A M van de Schans, Katja K H Aben, Peter F A Mulders, et al.
RSC Advances|May 11, 2022
A salt-based method to adapt stiffness and biodegradability of porous collagen scaffoldsLuuk R Versteegden, Marije Sloff, Henk R Hoogenkamp, et al.
Pageof 19